The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Guidelines for the definitions of time-to-event endpoints in randomized clinical trials: Results of the DATECAN Project for Sarcomas and GISTs.
Carine A. Bellera
No relevant relationships to disclose
Monia Ouali
No relevant relationships to disclose
Nicolas Penel
No relevant relationships to disclose
Sylvie Bonvalot
No relevant relationships to disclose
Paolo Giovanni Casali
No relevant relationships to disclose
Martine Delannes
No relevant relationships to disclose
Ole Steen Nielsen
No relevant relationships to disclose
Simone Mathoulin-Pelissier
No relevant relationships to disclose